Enveric Biosciences Inc ENVB

$1.44 -0.08 (-4.95%)

Valuation

Market cap
6,781,000
Revenue TTM
$0
Net income TTM
$-8,770,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
34,600
Avg volume
54,348
Day's range
$1.44 – $1.54
Shares out
4,476,000
Stochastic %K
33%
Beta
1.23
Analysts
—
Price target
$10.00

Price

Company profile

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indole...

Show more

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 444 8400
Website
https://www.enveric.com
Address
245 First Street, Riverview II 18 th Floor, Cambridge, United States

Latest news

Stocktwits

Troll85 Nov 9, 3:26 PM
$ENVB it’s about to take off this week 😎
0 replies
HazardousMayhem Nov 7, 3:02 AM
$ENVB 14k watching 🫠
0 replies
LibertarianTreehugger Nov 5, 4:33 PM
Enveric's Psychedelic-Inspired Drug Shows Promise in Early Research: https://jlsfund.substack.com/p/enverics-psychedelic-inspired-drug $ENVB
0 replies
prismmarketview Nov 4, 3:38 PM
$ENVB: EB-003 altered prefrontal and parietal brain-wave activity in mice (qEEG), distinct from DMT → No epileptic-like EEG activity or body spasms vs. DMT under study conditions → qEEG planned as a biomarker in first-in-human work Caveats: preclinical. No doses or numbers disclosed. Human safety, efficacy, and non-hallucinogenic profile unproven. No Phase 1 date. $ENVB #Psychedelics https://prismmarketview.com/enveric-reports-distinct-brain-activity-profile-for-eb-003-in-preclinical-study/
0 replies
Batcave26 Nov 3, 11:27 AM
$ENVB turd 💩 of a stock - CROOKS
0 replies
VegasOracle Oct 22, 12:33 AM
$ENVB https://www.benzinga.com/news/health-care/26/10/62491841/enveric-biosciences-reports-favorable-preclinical-results-for-non-hallucinogenic-psychiatric-candidate?utm_source=TechInvestorNews&utm_campaign=partner_feed&utm_medium=referral
0 replies
VegasOracle Oct 22, 12:32 AM
$ENVB Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate by Vandana Singh Benzinga Staff Writer
0 replies
Troll85 Oct 13, 6:59 PM
$ENVB wtf $100? 🤦‍♂️
1 replies